The Right Equity Release
  • About
    • Editorial Policy
    • Affiliate Disclosure
    • Contact The Right Equity Release
    • Privacy Policy
    • Disclaimer
    • Terms of Use
    • Impressum

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026

Categories

  • Aging in Place
  • Air Quality & Climate
  • Alternatives & Comparisons
  • Comfort & Wellness
  • Downsizing & Housing Options
  • Equity Release Basics
  • General
  • Home Fitness & Rehab
  • Home Office & Daily Living
  • Home Reversion Plans
  • Home Safety & Security
  • Legal Operations
  • Lifetime Mortgages
  • Market: Accounting operations
  • Market: IT services
  • Market: Wedding Technology
  • Mobility & Transfer
  • Power & Preparedness
  • Retirement & Care Funding
  • Sleep & Recovery
  • Uncategorized
  • Vetted
The Right Equity Release
  • About
    • Editorial Policy
    • Affiliate Disclosure
    • Contact The Right Equity Release
    • Privacy Policy
    • Disclaimer
    • Terms of Use
    • Impressum

Browsing Category

General

159 posts
  • General

SalMar – Record-strong Biological Performance

SalMar – Record-strong Biological Performance
SalMar announces unprecedented biological performance in its latest aquaculture report, highlighting improved growth rates and health metrics for its salmon farms.
  • The Right Equity Release Team
  • August 25, 2026
View Post
  • General

Piero Cipollone: Interview With Ilsussidiario.net

Piero Cipollone: Interview With Ilsussidiario.net
Piero Cipollone shares insights on the current economic situation in an interview with ilsussidiario.net, highlighting key challenges and future prospects.
  • The Right Equity Release Team
  • August 25, 2026
View Post
  • General

Anbogen Therapeutics And The University Of Tokyo Enter Collaborative Research Agreement To Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion

Anbogen Therapeutics And The University Of Tokyo Enter Collaborative Research Agreement To Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Anbogen Therapeutics and The University of Tokyo have announced a collaborative research agreement to evaluate ABT-301 across multiple tumor types, aiming to accelerate clinical development.
  • The Right Equity Release Team
  • August 24, 2026
View Post
  • General

Orum Therapeutics Announces U.S. FDA Clearance Of An IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate

Orum Therapeutics Announces U.S. FDA Clearance Of An IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate
Orum Therapeutics announced FDA clearance for an IND application for ORM-115, a novel CD123-GSPT1 degrader-antibody conjugate, advancing its clinical development.
  • The Right Equity Release Team
  • August 23, 2026
View Post
  • General

Quantum Biopharma Provides Corporate Update

Quantum Biopharma Provides Corporate Update
Quantum Biopharma releases a corporate update detailing recent developments, ongoing projects, and future plans, impacting investor and industry perspectives.
  • The Right Equity Release Team
  • August 22, 2026
View Post
  • General

Brady Corporation Announces Earnings Conference Call

Brady Corporation Announces Earnings Conference Call
Brady Corporation has announced its upcoming earnings conference call, scheduled for next week, to discuss quarterly financial results with investors.
  • The Right Equity Release Team
  • August 22, 2026
View Post
  • General

Havila Kystruten AS: Invitation To Q2 2026 Earnings Call Presentation

Havila Kystruten AS: Invitation To Q2 2026 Earnings Call Presentation
Havila Kystruten AS has invited investors and analysts to participate in its Q2 2026 earnings call presentation, scheduled for August 15, 2026.
  • The Right Equity Release Team
  • August 21, 2026
View Post
  • General

»Kölner Stadt-Anzeiger« Medien Bauen Um – 57 Vollzeitstellen Betroffen

»Kölner Stadt-Anzeiger« Medien Bauen Um – 57 Vollzeitstellen Betroffen
The Kölner Stadt-Anzeiger is restructuring its operations, impacting 57 full-time positions, as part of a broader media company adjustment.
  • The Right Equity Release Team
  • August 16, 2026
View Post
  • General

The Science Of Resilience: Einstein’s Parenting Advice For Modern Parents

The Science Of Resilience: Einstein’s Parenting Advice For Modern Parents
Research highlights how Albert Einstein’s advice to his son offers valuable insights for raising resilient children today.
  • Thorsten Meyer
  • August 15, 2026
View Post
  • General

Avicanna Reports Q2 2026 Financial Results

Avicanna Reports Q2 2026 Financial Results
Avicanna announced its financial results for Q2 2026, showing revenue growth and operational updates. Details highlight company performance for investors and stakeholders.
  • The Right Equity Release Team
  • August 15, 2026
View Post
The Unprecedented Open-Sourcing Of Qwen4 Architecture By Qwen
  • Market: IT services

The Unprecedented Open-Sourcing Of Qwen4 Architecture By Qwen

Qwen releases the architecture of its upcoming Qwen4 model as open source before its…
  • The Right Equity Release Team
  • August 26, 2026
Can GLM-5.3-Flash Deliver On Its Promise Of Cheap AI Agents?
  • Market: IT services

Can GLM-5.3-Flash Deliver On Its Promise Of Cheap AI Agents?

Z.ai's GLM-5.3-Flash is a 320-billion-parameter multimodal model promising low-cost,…
  • The Right Equity Release Team
  • August 26, 2026
Invesco International Buyback Achievers Surges In Global Coverage
  • Market: IT services

Invesco International Buyback Achievers Surges In Global Coverage

Invesco International Buyback Achievers experiences a surge in global coverage, with 14…
  • The Right Equity Release Team
  • August 26, 2026
15 Best Personal Finance Books for Recent Graduates in 2026
  • Vetted

15 Best Personal Finance Books for Recent Graduates in 2026

Discover the top personal finance books for recent graduates in 2026. Find the best…
  • The Right Equity Release Team
  • August 26, 2026
The Right Equity Release
  • Impressum
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Affiliate Disclosure
  • Contact
Copyright © 2026 The Right Equity Release Content on The Right Equity Release is created and published using artificial intelligence (AI) for general informational and educational purposes. Affiliate disclaimer As an affiliate, we may earn a commission from qualifying purchases. We get commissions for purchases made through links on this website from Amazon and other third parties.